Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

This study has been terminated.

( Accrual did not meet expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable. )

Study NCT01466504 Information provided by Dartmouth-Hitchcock Medical Center

First Received on October 31, 2011. Last Updated on April 11, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Interventions listed in this trial

skin punch biopsy

Additional drug interventions recognized in this trial

Sorafenib

More general drug interventions related to this trial

Sponsors listed in this trial